tiprankstipranks
Tharimmune granted patent for delivery of molecularly targeted therapeutics
PremiumThe FlyTharimmune granted patent for delivery of molecularly targeted therapeutics
3M ago
Tharimmune receives regulatory feedback from EMA for TH104 program
Premium
The Fly
Tharimmune receives regulatory feedback from EMA for TH104 program
3M ago
Tharimmune presents TH104 Phase 1 data at ACG Annual Meeting
Premium
The Fly
Tharimmune presents TH104 Phase 1 data at ACG Annual Meeting
3M ago
Tharimmune appoints David Jones to Scientific Advisory Board
PremiumThe FlyTharimmune appoints David Jones to Scientific Advisory Board
6M ago
Tharimmune appoints David Clarke as strategic advisor
Premium
The Fly
Tharimmune appoints David Clarke as strategic advisor
7M ago
Tharimmune launches new website amid continuing discussions wtih FDA
Premium
The Fly
Tharimmune launches new website amid continuing discussions wtih FDA
7M ago
Tharimmune announces results of Phase 1 trial of TH104
PremiumThe FlyTharimmune announces results of Phase 1 trial of TH104
8M ago
Tharimmune Inc trading halted, news pending
Premium
The Fly
Tharimmune Inc trading halted, news pending
8M ago
Tharimmune announces 1-for-15 reverse stock split
Premium
The Fly
Tharimmune announces 1-for-15 reverse stock split
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100